Article Details

AstraZeneca to Buy Chinese Cancer Drug Developer for Up to $1.2 Billion - Caixin Global

Retrieved on: 2023-12-26 19:30:58

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca to Buy Chinese Cancer Drug Developer for Up to $1.2 Billion - Caixin Global. View article details on hiswai:

Excerpt

(Bloomberg) — AstraZeneca Plc agreed to acquire Chinese cell therapy developer Gracell Biotechnologies Inc. for as much as $1.2 billion as the ...

Article found on: www.caixinglobal.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up